Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)

SHA:600867 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,036	1,976	2,930	2,742	3,219	2,855
Other Revenue	33.15	33.15	145.81	36.47	49.22	37.13
Revenue	2,070	2,010	3,075	2,778	3,268	2,892
Revenue Growth (YoY)	-31.05%	-34.66%	10.69%	-14.98%	12.99%	4.14%
Cost of Revenue	621.25	547.46	621.05	628.13	586.99	582.86
Gross Profit	1,448	1,462	2,454	2,150	2,681	2,309
Selling, General & Admin	1,351	1,252	1,047	1,114	1,255	1,091
Research & Development	109.92	99.3	104.96	146.71	166.86	106.93
Other Operating Expenses	15.82	13.13	11.65	14.57	11.27	-34.35
Operating Expenses	1,461	1,349	1,184	1,268	1,435	1,165
Operating Income	-12.83	113.02	1,270	882.29	1,246	1,145
Interest Expense	-17.25	-14.38	-5.17	-0.28	-	-10.17
Interest & Investment Income	134.59	130.82	103.61	942.66	304.32	43.64
Currency Exchange Gain (Loss)	0.7	0.7	0.47	0	0.24	-0.45
Other Non Operating Income (Expenses)	-0.28	-1.14	-1.65	-0.88	0.33	-7.38
EBT Excluding Unusual Items	104.93	229.02	1,368	1,824	1,550	1,170
Gain (Loss) on Sale of Investments	0.07	0.4	0.52	0.96	-0.37	0.37
Gain (Loss) on Sale of Assets	-239.94	-239.83	-3.13	-0.11	-13.48	-62.44
Asset Writedown	-80.68	-80.68	-7	-1.74	-11.53	-
Legal Settlements	-60.82	-60.82	-	-	-	-
Other Unusual Items	8.13	8.16	7.91	6.62	9.35	-
Pretax Income	-268.31	-143.75	1,366	1,830	1,534	1,108
Income Tax Expense	-116.23	-99.63	197.97	247.69	225.86	177.81
Earnings From Continuing Operations	-152.08	-44.12	1,168	1,582	1,309	930.32
Minority Interest in Earnings	3.85	1.4	-0.09	0.06	-0.34	-0.41
Net Income	-148.24	-42.72	1,168	1,582	1,308	929.92
Net Income to Common	-148.24	-42.72	1,168	1,582	1,308	929.92
Net Income Growth	-	-	-26.17%	20.92%	40.69%	14.63%
Shares Outstanding (Basic)	2,103	2,136	1,979	2,002	2,044	2,022
Shares Outstanding (Diluted)	2,103	2,136	1,979	2,002	2,044	2,022
Shares Change (YoY)	5.91%	7.92%	-1.15%	-2.04%	1.12%	-0.32%
EPS (Basic)	-0.07	-0.02	0.59	0.79	0.64	0.46
EPS (Diluted)	-0.07	-0.02	0.59	0.79	0.64	0.46
EPS Growth	-	-	-25.32%	23.44%	39.13%	15.00%
Free Cash Flow	-156.09	-108.99	513.4	370.21	579.62	712.69
Free Cash Flow Per Share	-0.07	-0.05	0.26	0.18	0.28	0.35
Dividend Per Share	0.250	0.250	0.250	0.500	0.300	0.210
Dividend Growth	-	-	-50.00%	66.67%	42.86%	5.00%
Gross Margin	69.98%	72.76%	79.81%	77.39%	82.04%	79.85%
Operating Margin	-0.62%	5.62%	41.31%	31.75%	38.12%	39.57%
Profit Margin	-7.16%	-2.13%	37.97%	56.93%	40.03%	32.15%
Free Cash Flow Margin	-7.54%	-5.42%	16.69%	13.32%	17.74%	24.64%
EBITDA	174.44	300.02	1,456	1,033	1,389	1,299
EBITDA Margin	8.43%	14.93%	47.35%	37.20%	42.51%	44.92%
D&A For EBITDA	187.28	187	185.87	151.17	143.65	154.54
EBIT	-12.83	113.02	1,270	882.29	1,246	1,145
EBIT Margin	-0.62%	5.62%	41.31%	31.75%	38.12%	39.57%
Effective Tax Rate	-	-	14.49%	13.54%	14.72%	16.05%
Revenue as Reported	2,070	2,010	3,075	2,778	3,268	-
Advertising Expenses	-	93.24	63.59	46.79	143.61	120.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.